ADVANCED POLICY CONSULTING, LLC for AMGEN USA INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Monitoring potential technical correction tax legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW MCGINLEY | — |
Health Issues HCR
Monitoring healthcare legislation. H.R. 3 "Lower Drug Costs Now Act of 2019." Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regard the Department on Health and Human Services' (HHS) International Pricing Index (IPI) Model, which would import single-payer government run price controls that limit innovation and patient access to life saving therapies. Support rebate rule to bring down the cost of drug prices. Education regarding the bio-similars market place. Support "The Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act" (HR 2693). Monitor COVID-19 legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW MCGINLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.